Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-01

Clinical Trial Update: Chart Review of Patients Undergoing Ketamine Treatments for Depression

View source ↗

Summary

A completed chart-review study examining outcomes for patients with major depressive disorder who underwent ketamine treatments for depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Depression - Major Depressive Disorder | Status: COMPLETED